Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary A Ulaner

Showing results (101-110 of 152) with videos related to

Pageof 16
Sort By:
Human Molecular Genetics|February 18, 2003
Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding siteGary A Ulaner, Thanh H Vu, Tao Li, et al.
Molecular Human Reproduction|October 13, 2005
IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switchTao Li, Thanh H Vu, Gary A Ulaner, et al.
Blood|March 12, 2015
Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphomaCraig S Sauter, Matthew J Matasar, Jessica Meikle, et al.
AJR. American Journal of Roentgenology|September 24, 2015
Detection of Internal Mammary Adenopathy in Patients With Breast Cancer by PET/CT and MRIMaxine S Jochelson, Lizza Lebron, Stefanie S Jacobs, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2021
Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic BiomarkerDavid L Chan, Gary A Ulaner, David Pattison, et al.
Radiology|July 19, 2022
<sup>18</sup>F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic ConfirmationGary A Ulaner, Beth Thomsen, Jeffrey Bassett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 13, 2024
Interreader and Intrareader Reproducibility of <sup>18</sup>F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter StudiesPhillip H Kuo, Giuseppe Esposito, Gary A Ulaner, et al.
Cancer Research|April 19, 2003
Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcomaGary A Ulaner, Hsuan-Ying Huang, Jesse Otero, et al.
Radiology|April 8, 2020
CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human ImagingGary A Ulaner, Nicholas B Sobol, Joseph A O'Donoghue, et al.
Radiology|June 10, 2020
Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted <sup>89</sup>Zr-Pertuzumab PET/CTGary A Ulaner, Jorge A Carrasquillo, Christopher C Riedl, et al.
Pageof 16

Showing results (101-110 of 152) with videos related to

Sort By:
Pageof 16
Human Molecular Genetics|February 18, 2003
Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding siteGary A Ulaner, Thanh H Vu, Tao Li, et al.
Molecular Human Reproduction|October 13, 2005
IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switchTao Li, Thanh H Vu, Gary A Ulaner, et al.
Blood|March 12, 2015
Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphomaCraig S Sauter, Matthew J Matasar, Jessica Meikle, et al.
AJR. American Journal of Roentgenology|September 24, 2015
Detection of Internal Mammary Adenopathy in Patients With Breast Cancer by PET/CT and MRIMaxine S Jochelson, Lizza Lebron, Stefanie S Jacobs, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2021
Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic BiomarkerDavid L Chan, Gary A Ulaner, David Pattison, et al.
Radiology|July 19, 2022
<sup>18</sup>F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic ConfirmationGary A Ulaner, Beth Thomsen, Jeffrey Bassett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 13, 2024
Interreader and Intrareader Reproducibility of <sup>18</sup>F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter StudiesPhillip H Kuo, Giuseppe Esposito, Gary A Ulaner, et al.
Cancer Research|April 19, 2003
Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcomaGary A Ulaner, Hsuan-Ying Huang, Jesse Otero, et al.
Radiology|April 8, 2020
CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human ImagingGary A Ulaner, Nicholas B Sobol, Joseph A O'Donoghue, et al.
Radiology|June 10, 2020
Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted <sup>89</sup>Zr-Pertuzumab PET/CTGary A Ulaner, Jorge A Carrasquillo, Christopher C Riedl, et al.
Pageof 16